ArticleFrontiers in immunology2025

A pilot transcriptomic study of a novel multitargeted BRT regimen for anti-MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy.

Moe Tokunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.